338 related articles for article (PubMed ID: 26719669)
1. Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer.
Gao S; Li J; Jiang C; Hong B; Hao B
Drug Des Devel Ther; 2016; 10():1-11. PubMed ID: 26719669
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
[TBL] [Abstract][Full Text] [Related]
3. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer.
Han L; Huang R; Li J; Liu S; Huang S; Jiang C
Biomaterials; 2011 Feb; 32(4):1242-52. PubMed ID: 20971503
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
Huang R; Ke W; Han L; Li J; Liu S; Jiang C
Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
[TBL] [Abstract][Full Text] [Related]
5. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
6. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Huang RQ; Qu YH; Ke WL; Zhu JH; Pei YY; Jiang C
FASEB J; 2007 Apr; 21(4):1117-25. PubMed ID: 17218540
[TBL] [Abstract][Full Text] [Related]
7. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
8. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells,
Pishavar E; Ramezani M; Hashemi M
Drug Dev Ind Pharm; 2019 Dec; 45(12):1931-1939. PubMed ID: 31609130
[TBL] [Abstract][Full Text] [Related]
10. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
[TBL] [Abstract][Full Text] [Related]
11. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.
Bai CZ; Choi S; Nam K; An S; Park JS
Int J Pharm; 2013 Mar; 445(1-2):79-87. PubMed ID: 23384727
[TBL] [Abstract][Full Text] [Related]
12. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
14. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
15. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
16. Modified PAMAM vehicles for effective TRAIL gene delivery to colon adenocarcinoma: in vitro and in vivo evaluation.
Pishavar E; Attaranzadeh A; Alibolandi M; Ramezani M; Hashemi M
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S503-S513. PubMed ID: 30095012
[TBL] [Abstract][Full Text] [Related]
17. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA
Tai Z; Ma J; Ding J; Pan H; Chai R; Zhu C; Cui Z; Chen Z; Zhu Q
Int J Nanomedicine; 2020; 15():10305-10320. PubMed ID: 33376323
[TBL] [Abstract][Full Text] [Related]
19. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.
Han L; Zhang A; Wang H; Pu P; Jiang X; Kang C; Chang J
Hum Gene Ther; 2010 Apr; 21(4):417-26. PubMed ID: 19899955
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma.
Zhang X; Zhao L; Zhai G; Ji J; Liu A
Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]